Using Probiotics Along with Regular Treatment to Help Manage Mild to Moderate Asthma: A Clinical Study from South India

A PROSPECTIVE STUDY TO COMPARE THE CLINICAL EFFICACY OF PROBIOTICS AS AN ADJUVANT TO STANDARD THERAPY IN A PATIENTS WITH MILD-MODERATE BRONCHIAL ASTHMA IN A TERTIARY CARE CENTRE IN SOUTH INDIA - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098954

Enrollment

Registered

2025-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Standard therapy for Bronchial Asthma with probiotics: Enrolled participants will be divided into two groups a) Standard therapy for Bronchial asthma, b) Standard therapy with probiotic

Eligibility

Inclusion criteria

Inclusion criteria: Male or female patient with age group between 18-45 years. Male or female patient, who met the diagnostic criteria for asthma, with temporarily stable asthmatic symptoms in non-acute attack stage that could be controlled by drug treatment. Patients willing to give written and informed consent. Conscious and co-operative patients

Exclusion criteria

Exclusion criteria: Patients not willing to give consent Male or female patient with any history of major disease, such as gastrointestinal diseases, long term requirement for glucocorticoids or other immunosuppressive agents, antibiotics intake 1 month before the trial.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of probiotics as an adjuvant therapy in the treatment of adults with moderate bronchial asthma.Timepoint: 8 weeks	—

Secondary

Measure	Time frame
To evaluate the reduction of drugs used in maintenance and as needed for asthma exacerbations. Timepoint: 8WEEKS	—

Countries

India

Contacts

Public ContactPREETHI S

ACS MEDICAL COLLEGE AND HOSPITAL

drbkalaiselvi@gmail.com9840311021

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026